全文获取类型
收费全文 | 79121篇 |
免费 | 6131篇 |
国内免费 | 252篇 |
专业分类
耳鼻咽喉 | 915篇 |
儿科学 | 2049篇 |
妇产科学 | 1113篇 |
基础医学 | 10649篇 |
口腔科学 | 890篇 |
临床医学 | 8405篇 |
内科学 | 16887篇 |
皮肤病学 | 989篇 |
神经病学 | 7691篇 |
特种医学 | 3051篇 |
外科学 | 12864篇 |
综合类 | 888篇 |
一般理论 | 93篇 |
预防医学 | 5970篇 |
眼科学 | 1956篇 |
药学 | 5429篇 |
中国医学 | 96篇 |
肿瘤学 | 5569篇 |
出版年
2023年 | 611篇 |
2022年 | 407篇 |
2021年 | 2228篇 |
2020年 | 1369篇 |
2019年 | 2218篇 |
2018年 | 2552篇 |
2017年 | 1825篇 |
2016年 | 1909篇 |
2015年 | 2235篇 |
2014年 | 3234篇 |
2013年 | 4096篇 |
2012年 | 6561篇 |
2011年 | 6802篇 |
2010年 | 3714篇 |
2009年 | 3271篇 |
2008年 | 5443篇 |
2007年 | 5643篇 |
2006年 | 5241篇 |
2005年 | 5187篇 |
2004年 | 4685篇 |
2003年 | 4278篇 |
2002年 | 3875篇 |
2001年 | 628篇 |
2000年 | 427篇 |
1999年 | 547篇 |
1998年 | 677篇 |
1997年 | 477篇 |
1996年 | 392篇 |
1995年 | 428篇 |
1994年 | 400篇 |
1993年 | 391篇 |
1992年 | 266篇 |
1991年 | 228篇 |
1990年 | 212篇 |
1989年 | 191篇 |
1988年 | 167篇 |
1987年 | 148篇 |
1986年 | 148篇 |
1985年 | 162篇 |
1984年 | 189篇 |
1983年 | 156篇 |
1982年 | 243篇 |
1981年 | 237篇 |
1980年 | 184篇 |
1979年 | 111篇 |
1978年 | 123篇 |
1977年 | 106篇 |
1976年 | 82篇 |
1975年 | 78篇 |
1974年 | 65篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
Peter J.G. Cussell Margarita Gomez Escalada Nathaniel G.N. Milton Andrew W.J. Paterson 《中国神经再生研究》2020,(7):1191-1198
N-formyl peptide receptors(FPRs)were first identified upon phagocytic leukocytes,but more than four decades of research has unearthed a plethora of non-myeloid roles for this receptor family.FPRs are expressed within neuronal tissues and markedly in the central nervous system,where FPR interactions with endogenous ligands have been implicated in the pathophysiology of several neurodegenerative diseases including Alzheimer's disease and Parkinson's disease,as well as neurological cancers such as neuroblastoma.Whilst the homeostatic function of FPRs in the nervous system is currently undefined,a variety of novel physiological roles for this receptor family in the neuronal context have been posited in both human and animal settings.Rapid developments in recent years have implicated FPRs in the process of neurogenesis and neuronal differentiation which,upon greater characterisation,could represent a novel pharmacological target for neuronal regeneration therapies that may be used in the treatment of brain/spinal cord injury,stroke and neurodegeneration.This review aims to summarize the recent progress made to determine the physiological role of FPRs in a neuronal setting,and to put forward a case for FPRs as a novel pharmacological target for conditions of the nervous system,and for their potential to open the door to novel neuronal regeneration therapies. 相似文献
52.
Katrina Hueniken MPH Catriona M. Douglas BSc MBChB MD Ashok R. Jethwa MD Maryam Mirshams MSc Lawson Eng MD Andrew Hope MD Douglas B. Chepeha MD David P. Goldstein MD MSc Jolie Ringash MD MSc Aaron Hansen BSc MBBS Rosemary Martino PhD Madeline Li MD PhD Geoffrey Liu MD Wei Xu MD John R. de Almeida MD MSc 《Cancer》2020,126(17):4042-4050
53.
54.
55.
56.
Mohamad Abbass Brendan G. Santyr Andrew G. Parrent Keith W. MacDougall Michael D. Staudt 《Neuromodulation》2020,23(6):831-837
ObjectiveStimulation of the dorsal spinal roots, or spinal nerve root stimulation (SNRS), is a neuromodulation modality that can target pain within specific dermatomal distributions. The use of paresthesia-free stimulation has been described with conventional dorsal column spinal cord stimulation, although has yet to be described for SNRS. This objective of this study was to investigate the efficacy of paresthesia-free high-frequency (1000–1200 Hz) SNRS in the treatment of intractable, dermatomal neuropathic pain.Materials and MethodsA retrospective chart review was performed on 14 patients implanted with SNRS in varying distributions: Ten patients initially received tonic stimulation and crossed over to a paresthesia-free paradigm and four patients received only paresthesia-free stimulation. The primary outcome was reduction in pain severity (visual analog scale [VAS]), measured at baseline and follow-up to 24 months with paresthesia-free stimulation.ResultsAll 14 patients who received paresthesia-free stimulation had significant improvement in pain severity at a mean follow-up of 1.39 ± 0.15 years (VAS 7.46 at baseline vs. 3.25 at most recent follow-up, p < 0.001). Ten patients were initially treated with tonic stimulation and crossed over to paresthesia-free stimulation after a mean of 61.7 months. Baseline pain in these crossover patients was significantly improved at last follow-up with tonic stimulation (VAS 7.65 at baseline vs. 2.83 at 48 months, p < 0.001), although all patients developed uncomfortable paresthesias. There was no significant difference in pain severity between patients receiving tonic and paresthesia-free stimulation.ConclusionsWe present real-world outcomes of patients with intractable dermatomal neuropathic pain treated with paresthesia-free, high-frequency SNRS. We demonstrate its effectiveness in providing pain reduction at a level comparable to tonic SNRS up to 24 months follow-up, without producing uncomfortable paresthesias. 相似文献
57.
58.
Yiliao Luo Mengxing Li Uday P. Pratap Suryavathi Viswanadhapalli Junhao Liu Prabhakar P. Venkata Kristin A. Altwegg Bridgitte E. Palacios Xiaonan Li Yihong Chen Manjeet K. Rao Andrew J. Brenner Gangadhara R. Sareddy Ratna K. Vadlamudi 《Molecular carcinogenesis》2020,59(3):281-292
Medulloblastoma (MB) is the most common and deadliest brain tumor in children. Proline-, glutamic acid-, and leucine-rich protein 1 (PELP1) is a scaffolding protein and its oncogenic signaling is implicated in the progression of several cancers. However, the role of PELP1 in the progression of MB remains unknown. The objective of this study is to examine the role of PELP1 in the progression of MB. Immunohistochemical analysis of MB tissue microarrays revealed that PELP1 is overexpressed in the MB specimens compared to normal brain. Knockdown of PELP1 reduced cell proliferation, cell survival, and cell invasion of MB cell lines. The RNA-sequencing analysis revealed that PELP1 knockdown significantly downregulated the pathways related to inflammation and extracellular matrix. Gene set enrichment analysis confirmed that the PELP1-regulated genes were negatively correlated with nuclear factor-κB (NF-κB), extracellular matrix, and angiogenesis gene sets. Interestingly, PELP1 knockdown reduced the expression of NF-κB target genes, NF-κB reporter activity, and inhibited the nuclear translocation of p65. Importantly, the knockdown of PELP1 significantly reduced in vivo MB progression in orthotopic models and improved the overall mice survival. Collectively, these results suggest that PELP1 could be a novel target for therapeutic intervention in MB. 相似文献
59.
60.